| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 16496 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 25463 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 27137 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 30304 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 33234 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 33281 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 35531 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 40698 | Peak area | DEHP treated |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 40711 | Peak area | Control |
| Reversed phase NEGATIVE ION MODE | 3-UREIDOPROPIONIC ACID (M-H)- | 44190 | Peak area | DEHP treated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|